|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Jun―22 |
In vitro and in silico studies of SARS-CoV-2 main protease Mpro inhibitors isolated from Helichrysum bracteatum |
Gehad Abdel Wahab, Walaa S. Aboelmaaty, Mohamed Farid Lahloub, Amal Sallam |
2 |
[GO] |
2022―Jun―22 |
A SARS-Cov-2 sensor based on upconversion nanoparticles and graphene oxide |
Konstantina Alexaki, Maria Eleni Kyriazi, Joshua Greening, Lapatrada Taemaitree, Afaf H. El-Sagheer, Tom Brown, et al. (+3) Xunli Zhang, Otto L. Muskens, Antonios G. Kanaras |
3 |
[GO] |
2022―May―31 |
Inhibition of SARS-CoV-2 spike protein entry using biologically modified polyacrylonitrile nanofibers: in vitro study towards specific antiviral masks |
Merna H. Emam, Hassan Nageh, Fedaa Ali, Mohamed Taha, Hasnaa A. ElShehaby, Rehab Amin, et al. (+3) Elbadawy A. Kamoun, Samah A. Loutfy, Amal Kasry |
4 |
[GO] |
2022―May―27 |
Pyrazolone-type compounds: synthesis and in silico assessment of antiviral potential against key viral proteins of SARS-CoV-2 |
Jovica Branković, Vesna M. Milovanović, Dušica Simijonović, Slađana Novaković, Zorica D. Petrović, Snežana S. Trifunović, et al. (+2) Goran A. Bogdanović, Vladimir P. Petrović |
5 |
[GO] |
2022―May―25 |
Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 (in silico and in vitro study) |
Samah A. Loutfy, Ahmed I. Abdel-Salam, Yassmin Moatasim, Mokhtar R. Gomaa, Nasra F. Abdel Fattah, Merna H. Emam, et al. (+7) Fedaa Ali, Hasnaa A. ElShehaby, Eman A. Ragab, Hanaa M. Alam El-Din, Ahmed Mostafa, Mohamed A. Ali, Amal Kasry |
6 |
[GO] |
2022―May―11 |
A new insight into the transfer and delivery of anti-SARS-CoV-2 drug Carmofur with the assistance of graphene oxide quantum dot as a highly efficient nanovector toward COVID-19 by molecular dynamics simulation |
Mahnaz Shahabi, Heidar Raissi |
7 |
[GO] |
2022―May―06 |
Green aspects of photocatalysts during corona pandemic: a promising role for the deactivation of COVID-19 virus |
Abhinandan Kumar, Vatika Soni, Pardeep Singh, Aftab Aslam Parwaz Khan, Mohammed Nazim, Satyabrata Mohapatra, et al. (+6) Vipin Saini, Pankaj Raizada, Chaudhery Mustansar Hussain, Mohamed Shaban, Hadi M. Marwani, Abdullah M. Asiri |
8 |
[GO] |
2022―Mar―28 |
Rapid diagnosis of COVID-19 via nano-biosensor-implemented biomedical utilization: a systematic review |
Mohammad Harun-Ur-Rashid, Tahmina Foyez, Israt Jahan, Kaushik Pal, Abu Bin Imran |
9 |
[GO] |
2022―Mar―25 |
Cold atmospheric pressure plasma for attenuation of SARS-CoV-2 spike protein binding to ACE2 protein and the RNA deactivation |
Rakesh Ruchel Khanikar, Monalisa Kalita, Parismita Kalita, Bhaswati Kashyap, Santanu Das, Mojibur R. Khan, et al. (+2) Heremba Bailung, Kamatchi Sankaranarayanan |
10 |
[GO] |
2022―Mar―23 |
Gate-all-around junctionless FET based label-free dielectric/charge modulation detection of SARS-CoV-2 virus |
Kumari Nibha Priyadarshani, Sangeeta Singh, Mustafa K. A. Mohammed |
11 |
[GO] |
2022―Mar―10 |
Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics |
Farah Anjum, Md Nayab Sulaimani, Alaa Shafie, Taj Mohammad, Ghulam Md. Ashraf, Anwar L. Bilgrami, et al. (+4) Fahad A. Alhumaydhi, Suliman A. Alsagaby, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan |
12 |
[GO] |
2022―Feb―16 |
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal |
Prateek Kumar, Taniya Bhardwaj, Rajanish Giri |
13 |
[GO] |
2022―Feb―14 |
Exploration of plant-derived natural polyphenols toward COVID-19 main protease inhibitors: DFT, molecular docking approach, and molecular dynamics simulations |
Yufei Ma, Yulian Tao, Hanyang Qu, Cuihong Wang, Fei Yan, Xiujun Gao, Meiling Zhang |
14 |
[GO] |
2022―Feb―02 |
Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods |
Md. Oliullah Rafi, Khattab Al-Khafaji, Md. Takim Sarker, Tugba Taskin-Tok, Abdus Samad Rana, Md. Shahedur Rahman |
15 |
[GO] |
2022―Jan―28 |
Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro |
Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Binh Khanh Mai |
16 |
[GO] |
2022―Jan―28 |
Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach |
Kandhan Palanisamy, S. M. Esther Rubavathy, Muthuramalingam Prakash, Ramasamy Thilagavathi, Maryam S. Hosseini-Zare, Chelliah Selvam |
17 |
[GO] |
2022―Jan―25 |
A rapid water bath PCR combined with lateral flow assay for the simultaneous detection of SARS-CoV-2 and influenza B virus |
Hong Chen, Yunxiang Wang, Hongjuan Wei, Zhen Rong, Shengqi Wang |
18 |
[GO] |
2022―Jan―20 |
Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase |
Abdo A. Elfiky, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim, Wael M. Elshemey |
19 |
[GO] |
2021―Dec―17 |
GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2 |
Rahat Alam, Raihan Rahman Imon, Md. Enamul Kabir Talukder, Shahina Akhter, Md. Alam Hossain, Foysal Ahammad, Md. Mashiar Rahman |
20 |
[GO] |
2021―Dec―10 |
The dolabellane diterpenes as potential inhibitors of the SARS-CoV-2 main protease: molecular insight of the inhibitory mechanism through computational studies |
Nanik Siti Aminah, Muhammad Ikhlas Abdjan, Andika Pramudya Wardana, Alfinda Novi Kristanti, Imam Siswanto, Khusna Arif Rakhman, Yoshiaki Takaya |
21 |
[GO] |
2021―Dec―10 |
Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases |
Vijay Sai Krishna Cheerala, Prasanth Ghanta, Sundaresan Chittor Neelakantan |
22 |
[GO] |
2021―Dec―03 |
Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins |
Mohammad Uzzal Hossain, Ishtiaque Ahammad, Arittra Bhattacharjee, Zeshan Mahmud Chowdhury, Md. Tabassum Hossain Emon, Keshob Chandra Das, et al. (+2) Chaman Ara Keya, Md. Salimullah |
23 |
[GO] |
2021―Dec―01 |
In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors |
Samia A. Elseginy, Manal M. Anwar |
24 |
[GO] |
2021―Nov―29 |
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations |
Nguyen Minh Tam, Duc-Hung Pham, Dinh Minh Hiep, Phuong-Thao Tran, Duong Tuan Quang, Son Tung Ngo |
25 |
[GO] |
2021―Nov―18 |
Identifying the specific-targeted marine cerebrosides against SARS-CoV-2: an integrated computational approach |
Eman Maher Zahran, Ahmed M. Sayed, Miada F. Abdelwahab, Amgad Albohy, Basma S. Abdulrazik, Ayman M. Ibrahim, et al. (+2) Gerhard Bringmann, Usama Ramadan Abdelmohsen |
26 |
[GO] |
2021―Nov―10 |
Computational methods directed towards drug repurposing for COVID-19: advantages and limitations |
Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, et al. (+3) Shubhra Chaturvedi, Dhruv Kumar, Brijesh Rathi |
27 |
[GO] |
2021―Nov―10 |
Determination of sodium and potassium ions in patients with SARS-Cov-2 disease by ion-selective electrodes based on polyelectrolyte complexes as a pseudo-liquid contact phase |
Liubov V. Pershina, Andrei R. Grabeklis, Ludmila N. Isankina, Ekaterina V. Skorb, Konstantin G. Nikolaev |
28 |
[GO] |
2021―Nov―03 |
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization |
Mohammed I. A. Hamed, Khaled M. Darwish, Raya Soltane, Amani Chrouda, Ahmed Mostafa, Noura M. Abo Shama, et al. (+5) Sameh S. Elhady, Hamada S. Abulkhair, Ahmed E. Khodir, Ayman Abo Elmaaty, Ahmed A. Al-karmalawy |
29 |
[GO] |
2021―Nov―01 |
Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19 |
Letícia Cristina Assis, Alexandre Alves de Castro, João Paulo Almirão de Jesus, Elaine Fontes Ferreira da Cunha, Eugenie Nepovimova, Ondrej Krejcar, et al. (+3) Kamil Kuca, Teodorico Castro Ramalho, Felipe de Almeida La Porta |
30 |
[GO] |
2021―Oct―25 |
A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients |
Mohammad Ali Khayamian, Mohammad Salemizadeh Parizi, Mohammadreza Ghaderinia, Hamed Abadijoo, Shohreh Vanaei, Hossein Simaee, et al. (+8) Saeed Abdolhosseini, Shahriar Shalileh, Mahsa Faramarzpour, Vahid Fadaei Naeini, Parisa Hoseinpour, Fatemeh Shojaeian, Fereshteh Abbasvandi, Mohammad Abdolahad |
31 |
[GO] |
2021―Oct―14 |
Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant |
Son Tung Ngo, Trung Hai Nguyen, Duc-Hung Pham, Nguyen Thanh Tung, Pham Cam Nam |
32 |
[GO] |
2021―Oct―13 |
Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening |
Oludare M. Ogunyemi, Gideon A. Gyebi, Ibrahim M. Ibrahim, Charles O. Olaiya, Joshua O. Ocheje, Modupe M. Fabusiwa, Joseph O. Adebayo |
33 |
[GO] |
2021―Sep―30 |
Chemical constituents from Limonium tubiflorum and their in silico evaluation as potential antiviral agents against SARS-CoV-2 |
Ahmed R. Hassan, Ibrahim M. Sanad, Ahmed E. Allam, Mohamed E. Abouelela, Ahmed M. Sayed, Shalabia S. Emam, et al. (+2) Salah M. El-Kousy, Kuniyoshi Shimizu |
34 |
[GO] |
2021―Sep―22 |
Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants |
Nadim Ferdous, Mahjerin Nasrin Reza, Md. Shariful Islam, Md. Tabassum Hossain Emon, A. K. M. Mohiuddin, Mohammad Uzzal Hossain |
35 |
[GO] |
2021―Sep―22 |
Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors |
Amr El-Demerdash, Ahmed A. Al-Karmalawy, Tarek Mohamed Abdel-Aziz, Sameh S. Elhady, Khaled M. Darwish, Ahmed H. E. Hassan |
36 |
[GO] |
2021―Sep―16 |
Bis-indolylation of aldehydes and ketones using silica-supported FeCl3: molecular docking studies of bisindoles by targeting SARS-CoV-2 main protease binding sites |
Barnali Deb, Sudhan Debnath, Ankita Chakraborty, Swapan Majumdar |
37 |
[GO] |
2021―Sep―09 |
The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective |
Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, et al. (+10) Abdullah Shah, Arsala Khan, Liaqat Ali, Zeeshan Anwar, Muhammad Safdar, Jehad Abubaker, N. Nizam Uddin, Liqiang Cao, Dong-Qing Wei, Anwar Mohammad |
38 |
[GO] |
2021―Sep―02 |
Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow |
Dweipayan Goswami |
39 |
[GO] |
2021―Aug―03 |
In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts |
Daniel M. Shadrack, Said A. H. Vuai, Mtabazi G. Sahini, Isaac Onoka |
40 |
[GO] |
2021―Aug―02 |
Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19 |
M. Abd Elkodous, S. O. Olojede, Mahmoud Morsi, Gharieb S. El-Sayyad |
41 |
[GO] |
2021―Jul―26 |
Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy |
John Eder Sanchez, Sierra A. Jaramillo, Erik Settles, J. Jesus Velazquez Salazar, Alexander Lehr, Javier Gonzalez, et al. (+9) Carmen Rodríguez Aranda, Hugo R. Navarro-Contreras, Marlee O. Raniere, Maxx Harvey, David M. Wagner, Andrew Koppisch, Robert Kellar, Paul Keim, Miguel Jose Yacaman |
42 |
[GO] |
2021―Jul―02 |
Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2 |
José Rogério A. Silva, Hendrik G. Kruger, Fábio A. Molfetta |
43 |
[GO] |
2021―Jun―24 |
In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp |
Ahmed E. Allam, Yhiya Amen, Ahmed Ashour, Hamdy K. Assaf, Heba Ali Hassan, Islam M. Abdel-Rahman, et al. (+2) Ahmed M. Sayed, Kuniyoshi Shimizu |
44 |
[GO] |
2021―Jun―23 |
Potential inhibitors for SARS-CoV-2 Mpro from marine compounds |
Nguyen Minh Tam, Minh Quan Pham, Huy Truong Nguyen, Nam Dao Hong, Nguyen Khoa Hien, Duong Tuan Quang, et al. (+2) Huong Thi Thu Phung, Son Tung Ngo |
45 |
[GO] |
2021―Jun―09 |
A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2 |
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu |
46 |
[GO] |
2021―Jun―04 |
Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors |
Abdelsamed I. Elshamy, Tarik A. Mohamed, Mahmoud A. A. Ibrahim, Mohamed A. M. Atia, Tatsuro Yoneyama, Akemi Umeyama, Mohamed-Elamir F. Hegazy |
47 |
[GO] |
2021―May―28 |
3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies |
Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, Atefeh Derakhshani, Javad Esmaeili, Aboulfazl Barati |
48 |
[GO] |
2021―May―19 |
Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2 |
Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, Hussam Albassam, Abdulrahman A. Almehizia, Ali M. Alqahtani, et al. (+3) Shafi Mahmud, Saad Ahmed Sami, Talha Bin Emran |
49 |
[GO] |
2021―May―12 |
A review on potential of natural products in the management of COVID-19 |
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, et al. (+2) Syamal Roy, Dipanjan Ghosh |
50 |
[GO] |
2021―May―12 |
Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2 |
Nguyen Minh Tam, Minh Quan Pham, Nguyen Xuan Ha, Pham Cam Nam, Huong Thi Thu Phung |
51 |
[GO] |
2021―May―10 |
Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay |
Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, et al. (+4) Hong Liu, Yalun Li, Tianyuan Wang, Yuxi Wang |
52 |
[GO] |
2021―May―05 |
Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2 |
Marvin J. Núñez, Bárbara I. Díaz-Eufracio, José L. Medina-Franco, Dionisio A. Olmedo |
53 |
[GO] |
2021―Apr―12 |
Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2 |
Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Hesham Refaat, Eman Alaaeldin, Omar M. Aly, et al. (+2) Mahmoud A. Elrehany, Mohamed S. Kamel |
54 |
[GO] |
2021―Apr―07 |
Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach |
Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK, Suresh Kumar Mohankumar |
55 |
[GO] |
2021―Mar―25 |
The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study |
Zhimin Wu, Xiaoxue Chen, Weiju Ni, Danshui Zhou, Shanshan Chai, Weile Ye, et al. (+4) Zhengpu Zhang, Yuanqiang Guo, Liping Ren, Yu Zeng |
56 |
[GO] |
2021―Mar―24 |
A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases |
Anju Choorakottayil Pushkaran, Prajeesh Nath EN, Anu R. Melge, Rammanohar Puthiyedath, C. Gopi Mohan |
57 |
[GO] |
2021―Mar―09 |
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study |
Ayman Abo Elmaaty, Radwan Alnajjar, Mohammed I. A. Hamed, Muhammad Khattab, Mohamed M. Khalifa, Ahmed A. Al-Karmalawy |
58 |
[GO] |
2021―Feb―25 |
Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study |
Jixue Sun, Meijiang Liu, Na Yang |
59 |
[GO] |
2021―Feb―08 |
A comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics |
Gayathri Pullangott, Uthradevi Kannan, Gayathri S., Degala Venkata Kiran, Shihabudheen M. Maliyekkal |
60 |
[GO] |
2021―Feb―02 |
Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies |
Shivkumar Patel, Amit Kumar Srivastav, Sanjeev K. Gupta, Umesh Kumar, S. K. Mahapatra, P. N. Gajjar, I. Banerjee |
61 |
[GO] |
2021―Jan―27 |
Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19 |
Pukar Khanal, Yadu Nandan Dey, Rajesh Patil, Rupesh Chikhale, Manish M. Wanjari, Shailendra S. Gurav, et al. (+3) B. M. Patil, Bhavana Srivastava, Sudesh N. Gaidhani |
62 |
[GO] |
2021―Jan―22 |
Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 Mpro inhibitors |
Nada M. Mohamed, Eslam M. H. Ali, Asmaa M. AboulMagd |
63 |
[GO] |
2021―Jan―19 |
In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection |
Yogesh Badhe, Rakesh Gupta, Beena Rai |
64 |
[GO] |
2021―Jan―15 |
Correction: The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives |
Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang |
65 |
[GO] |
2021―Jan―14 |
Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations |
Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka |
66 |
[GO] |
2021―Jan―13 |
Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro |
Nguyen Minh Tam, Pham Cam Nam, Duong Tuan Quang, Nguyen Thanh Tung, Van V. Vu, Son Tung Ngo |
67 |
[GO] |
2021―Jan―13 |
Inhibitory activity of quercetin, its metabolite, and standard antiviral drugs towards enzymes essential for SARS-CoV-2: the role of acid-base equilibria |
Žiko B. Milanović, Marko R. Antonijević, Ana D. Amić, Edina H. Avdović, Dušan S. Dimić, Dejan A. Milenković, Zoran S. Marković |
68 |
[GO] |
2021―Jan―04 |
Immune response and possible therapeutics in COVID-19 |
Anindya Dutta, Ananya Roy, Laboni Roy, Samit Chattopadhyay, Subhrangsu Chatterjee |
69 |
[GO] |
2020―Dec―14 |
Interpretation of SARS-CoV-2 behaviour on different substrates and denaturation of virions using ethanol: an atomic force microscopy study |
Umit Celik, Kubra Celik, Suleyman Celik, Hasan Abayli, Kezban Can Sahna, Şükrü Tonbak, et al. (+2) Zulal Asci Toraman, Ahmet Oral |
70 |
[GO] |
2020―Dec―07 |
1-Phenyl-N-(benzothiazol-2-yl)methanimine derivatives as Middle East respiratory syndrome coronavirus inhibitors |
Min-Qi Hu, Heng Li, Ying Lin, Ying Zhang, Jie Tang, Jian-Ping Zuo, et al. (+4) Li-Fang Yu, Xian-Kun Tong, Wei Tang, Fan Yang |
71 |
[GO] |
2020―Nov―26 |
In silico identification of SARS-CoV-2 spike (S) protein-ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS |
Seham S. El Hawary, Amira R. Khattab, Hanan S. Marzouk, Amira S. El Senousy, Mariam G. A. Alex, Omar M. Aly, et al. (+2) Mohamed Teleb, Usama Ramadan Abdelmohsen |
72 |
[GO] |
2020―Nov―25 |
Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro |
Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talha Jawaid |
73 |
[GO] |
2020―Nov―10 |
Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19) |
Simona De Vita, Maria Giovanna Chini, Gianluigi Lauro, Giuseppe Bifulco |
74 |
[GO] |
2020―Nov―09 |
Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations |
Son Tung Ngo, Hung Minh Nguyen, Le Thi Thuy Huong, Pham Minh Quan, Vi Khanh Truong, Nguyen Thanh Tung, Van V. Vu |
75 |
[GO] |
2020―Nov―06 |
The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives |
Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang |
76 |
[GO] |
2020―Nov―04 |
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease |
Vladimir Frecer, Stanislav Miertus |
77 |
[GO] |
2020―Nov―04 |
Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro |
Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talaha Jawed |
78 |
[GO] |
2020―Nov―02 |
Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein |
Puja Adhikari, Wai-Yim Ching |
79 |
[GO] |
2020―Nov―01 |
ACE2 as a potential therapeutic target for pandemic COVID-19 |
Bhaswati Chatterjee, Suman S. Thakur |
80 |
[GO] |
2020―Oct―15 |
Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure-activity relationships, molecular modeling and impact on its folk medicinal uses |
Sherif S. Ebada, Nariman A. Al-Jawabri, Fadia S. Youssef, Dina H. El-Kashef, Tim-Oliver Knedel, Amgad Albohy, et al. (+9) Michal Korinek, Tsong-Long Hwang, Bing-Hung Chen, Guan-Hua Lin, Chia-Yi Lin, Sa'ed M. Aldalaien, Ahmad M. Disi, Christoph Janiak, Peter Proksch |
81 |
[GO] |
2020―Oct―13 |
Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study |
Malvi Surti, Mitesh Patel, Mohd Adnan, Afrasim Moin, Syed Amir Ashraf, Arif Jamal Siddiqui, et al. (+3) Mejdi Snoussi, Sumukh Deshpande, Mandadi Narsimha Reddy |
82 |
[GO] |
2020―Sep―30 |
Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework |
Neeraj Kumar, Damini Sood, Ramesh Chandra |
83 |
[GO] |
2020―Sep―23 |
Diagnostic technologies for COVID-19: a review |
Qi Chen, Zhenyun He, Fujing Mao, Hua Pei, Hongmei Cao, Xing Liu |
84 |
[GO] |
2020―Sep―23 |
Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach |
Dejan A. Milenković, Dušan S. Dimić, Edina H. Avdović, Zoran S. Marković |
85 |
[GO] |
2020―Sep―18 |
Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors |
Tarik A. Mohamed, Abdelsamed I. Elshamy, Mahmoud A. A. Ibrahim, Ammar Zellagui, Mahmoud F. Moustafa, Alaa H. M. Abdelrahman, et al. (+3) Shinji Ohta, Paul W. Pare, Mohamed-Elamir F. Hegazy |
86 |
[GO] |
2020―Sep―15 |
Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins |
Mostafa A. Mansour, Asmaa M. AboulMagd, Hamdy M. Abdel-Rahman |
87 |
[GO] |
2020―Sep―15 |
Automated multiplex nucleic acid tests for rapid detection of SARS-CoV-2, influenza A and B infection with direct reverse-transcription quantitative PCR (dirRT-qPCR) assay in a centrifugal microfluidic platform |
Minghui Ji, Yun Xia, Jacky Fong-Chuen Loo, Lang Li, Ho-Pui Ho, Jianan He, Dayong Gu |
88 |
[GO] |
2020―Sep―04 |
Development of a tablet PC-based portable device for colorimetric determination of assays including COVID-19 and other pathogenic microorganisms |
Woo Sik Yoo, Hyung Soo Han, Jung Gon Kim, Kitaek Kang, Hyo-Sung Jeon, Jin-Young Moon, Hyeonmi Park |
89 |
[GO] |
2020―Aug―28 |
Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening |
Fatma M. Abd El-Mordy, Mohamed M. El-Hamouly, Magda T. Ibrahim, Gehad Abd El-Rheem, Omar M. Aly, Adel M. Abd El-kader, et al. (+2) Khayrya A. Youssif, Usama Ramadan Abdelmohsen |
90 |
[GO] |
2020―Aug―28 |
Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations |
Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, et al. (+3) Van V. Vu, Trung Hai Nguyen, Son Tung Ngo |
91 |
[GO] |
2020―Aug―25 |
Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets |
Dhivya Shanmugarajan, Prabitha P., B. R. Prashantha Kumar, B. Suresh |
92 |
[GO] |
2020―Aug―21 |
A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation |
Thanh Q. Bui, Huynh Thi Phuong Loan, Tran Thi Ai My, Duong Tuan Quang, Bui Thi Phuong Thuy, Vo Duy Nhan, et al. (+6) Phan Tu Quy, Pham Van Tat, Duy Quang Dao, Nguyen Tien Trung, Lam K. Huynh, Nguyen Thi Ai Nhung |
93 |
[GO] |
2020―Aug―13 |
An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19 |
Ahmed E. Allam, Hamdy K. Assaf, Heba Ali Hassan, Kuniyoshi Shimizu, Yaseen A. M. M. Elshaier |
94 |
[GO] |
2020―Aug―13 |
Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies |
Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty, Sivaraman Jayanthi, Mallika Alvala |
95 |
[GO] |
2020―Jul―29 |
Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review |
Maryam S. Hosseini-Zare, Ramasamy Thilagavathi, Chelliah Selvam |
96 |
[GO] |
2020―Jul―28 |
A facile assay for rapid detection of COVID-19 antibodies |
Caixia Liu, Baiping Mao, Vanessa Martinez, Xiaojian Chen, Yanan Li, Lingyun He, et al. (+9) Sian Chen, Xiaoling Guo, Xian Shen, Xiandan Bao, Haifa Shen, Stefania Lenna, Pinyi Qian, Lingzhi Wu, Chao Li |
97 |
[GO] |
2020―Jul―28 |
An overview of key potential therapeutic strategies for combat in the COVID-19 battle |
Gaurav Das, Surojit Ghosh, Shubham Garg, Satyajit Ghosh, Aniket Jana, Ramkamal Samat, et al. (+3) Nabanita Mukherjee, Rajsekhar Roy, Surajit Ghosh |
98 |
[GO] |
2020―Jul―27 |
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses |
Eman Shawky, Ahmed A. Nada, Reham S. Ibrahim |
99 |
[GO] |
2020―Jul―17 |
Potential repurposed SARS-CoV-2 (COVID-19) infection drugs |
Gamal El-Din A. Abuo-Rahma, Mamdouh F. A. Mohamed, Tarek S. Ibrahim, Mai E. Shoman, Ebtihal Samir, Rehab M. Abd El-Baky |
100 |
[GO] |
2020―Jul―17 |
Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 |
Shruti Koulgi, Vinod Jani, Mallikarjunachari V. N. Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi |
101 |
[GO] |
2020―Jul―01 |
Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease |
Marisa G. Santibáñez-Morán, Edgar López-López, Fernando D. Prieto-Martínez, Norberto Sánchez-Cruz, José L. Medina-Franco |
102 |
[GO] |
2020―Jun―19 |
Natural products' role against COVID-19 |
Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio Veiga-Junior |
103 |
[GO] |
2020―Jun―15 |
Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus |
Yang Chen, Hui Li, Li Wu, Mingxin Zhang, Yarou Gao, Heng Wang, et al. (+4) Dan Xu, Weisan Chen, Gaopeng Song, Jianxin Chen |
104 |
[GO] |
2020―May―21 |
Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease |
Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Omar M. Aly, Usama Ramadan Abdelmohsen, Mohamed S. Kamel |
105 |
[GO] |
2020―Apr―21 |
Anti-HIV drug repurposing against SARS-CoV-2 |
Peng Sang, Shu-Hui Tian, Zhao-Hui Meng, Li-Quan Yang |
106 |
[GO] |
2020―Apr―07 |
High antiviral activity of mercaptoethane sulfonate functionalized Te/BSA nanostars against arterivirus and coronavirus |
Yanrong Zhou, Xiaohan Jiang, Ting Tong, Liurong Fang, Yuan Wu, Jiangong Liang, Shaobo Xiao |